BCL2L12 and neoplasm: Intravenous administration of gold SNAs conjugating with Bcl2L12-targeting siRNAs reduced Bcl2L12 mRNA levels, increased apoptosis, and decreased tumor burden in a mouse orthotopic xenograft model [128].